Caldarella Maria Pia, Milano Angelo, Laterza Francesco, Sacco Flora, Balatsinou Crysanthi, Lapenna Domenico, Pierdomenico Sante Donato, Cuccurullo Franco, Neri Matteo
Department of Medicine and Ageing Sciences, Section of Internal Medicine and Gastroenterology, Gabriele D'Annunzio University and Foundation, 66100 Chieti, Italy.
Am J Gastroenterol. 2005 Feb;100(2):383-9. doi: 10.1111/j.1572-0241.2005.40100.x.
Visceral hypersensitivity is common in Irritable Bowel Syndrome (IBS) patients, and symptoms exacerbate postprandially. Yet the effects of nutrients on visceral sensitivity and symptoms in these patients have not been fully explored.
To evaluate the differences of visceral sensitivity and symptoms in healthy subjects and IBS patients during fasting and intraduodenal lipids infusion.
Graded rectal distensions at fixed tension levels were performed in 16 IBS patients (8 IBS-C and 8 IBS-D) and 6 healthy subjects before and during intraduodenal lipids infusion at 0.5 kcal/min. Tension levels were increased in 4 gr increments up to 64 gr or discomfort during both conditions. At each step, perception and symptoms were measured by means of a validated questionnaire.
In basal conditions, perception thresholds in IBS patients and health were, respectively, 8 +/- 2 gr versus 32 +/- 9 gr (p < 0.001) with no changes during lipids. Intraduodenal lipids infusion significantly lowered threshold of discomfort in IBS patients in comparison to fasting (24 +/- 6 gr vs 34 +/- 4 gr; p < 0.05), while health tolerated all distension without discomfort. No differences of compliance, perception, or discomfort were observed between the two subgroups of patients at each tension step. The predominant symptom elicited in patients with IBS-C was abdominal pain (54%), while patients with IBS-D exhibited urgency (63%, p < 0.005); this pattern was maintained during lipids.
Intraduodenal lipids increase visceral sensitivity in both IBS-C and IBS-D; symptoms specificity in response to rectal distension is maintained in the postprandial period. Lipids may be responsible for the postprandial symptoms exacerbation in IBS.
内脏高敏感性在肠易激综合征(IBS)患者中很常见,且症状在餐后会加重。然而,营养素对这些患者内脏敏感性和症状的影响尚未得到充分研究。
评估健康受试者和IBS患者在禁食和十二指肠内输注脂质期间内脏敏感性和症状的差异。
对16例IBS患者(8例便秘型IBS和8例腹泻型IBS)和6例健康受试者在以0.5千卡/分钟的速度十二指肠内输注脂质之前和期间,在固定张力水平下进行分级直肠扩张。在两种情况下,张力水平以4克的增量增加,直至64克或出现不适。在每个步骤中,通过经过验证的问卷测量感觉和症状。
在基础状态下,IBS患者和健康人的感觉阈值分别为8±2克和32±9克(p<0.001),在输注脂质期间无变化。与禁食相比,十二指肠内输注脂质显著降低了IBS患者的不适阈值(24±6克对34±4克;p<0.05),而健康人耐受所有扩张且无不适。在每个张力步骤中,两组患者在顺应性、感觉或不适方面均未观察到差异。便秘型IBS患者中引发的主要症状是腹痛(54%),而腹泻型IBS患者表现为急迫感(63%,p<0.005);这种模式在输注脂质期间保持不变。
十二指肠内输注脂质会增加便秘型IBS和腹泻型IBS患者的内脏敏感性;餐后直肠扩张时症状的特异性得以维持。脂质可能是IBS患者餐后症状加重的原因。